search

Active clinical trials for "Lung Neoplasms"

Results 6501-6510 of 6521

Gene Mutations in Non-Small Cell Lung Cancer Cells

CarcinomaNon-Small-Cell Lung

To compare the frequency of individual genetic abnormality between tumor cells and blood specimens.

Unknown status8 enrollment criteria

Validation of a Multi-gene Test for Lung Cancer Risk

Lung Cancer

The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.

Unknown status3 enrollment criteria

Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and...

Non Small Cell Lung Cancer

Xenografts and cell cultures provide sufficient material for analyses at the protein, RNA and DNA level. Patient derived NSCLC xenografts and cell lines are available but none however are Asian in origin. Given the emerging evidence to suggest inter-ethnic differences in NSCLC biology, new models of preclinical drug evaluation should be designed and validated using Asian tumors. Furthermore, such models will allow studies of biological mechanisms of sensitivity and/or resistance and also the study of dynamic regulations under standardized conditions in the Asian context.

Unknown status3 enrollment criteria

Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV...

Non Small Cell Lung Carcinoma

The primary aim of this non interventional study is to assess the independent prognostic role on overall survival of primary tumour 18F-FDG uptake value (SUVmax) measured on 18fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in patients with non-metastatic non-small cell lung cancers treated with curative intent, taking into account the other conventional prognostic factors (performance status, age, sex, disease stage).

Unknown status14 enrollment criteria

Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC)...

Non-Small Cell Lung Cancer

Recently it has been suggested that specific mutations in the EGFR gene in lung cancer patients is associated with response to a novel drug targeting the EGF system. Recent research also indicates that there is a possible association to the degree of aggressiveness of the disease. The importance of these mutations is controversial, because the data are based on small studies with highly selected patients. In this project the investigators want to study the types and frequencies of EGFR mutations in both untreated and treated patients in a systematic manner and relate this to survival. The thorough registration of patient data in DK enables us to create a strong The investigators expect this knowledge to be of greatest importance for future rational use of drugs targeting the EGF receptors.

Unknown status2 enrollment criteria

Sleep Disturbance in Lung Cancer Patients.

Lung Cancer

The aim of this study is to 1-evaluate subjectively by questionnaires and objectively by ambulatory actigraphy the quality of sleep in patients with newly diagnosed lung cancer; 2- to correlate sleep quality index with quality of life, daytime alertness, Performans status and lung cancer staging at diagnosis.

Unknown status2 enrollment criteria

SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis

Non-Small Cell Lung Cancer

To evaluate the correlation between SERPIN D1 expression in clinical specimen (including surgical specimen and blood sample) and lung cancer metastasis.

Unknown status2 enrollment criteria

An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

Lung Cancer

This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.

Unknown status7 enrollment criteria

Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization

Lung Cancer and Idiopathic Pulmonary Fibrosis

Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the records of the pulmonology and pathology departments of our various partners.

Unknown status3 enrollment criteria

A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History.

Lung NeoplasmsFamily Research

The aim of the present prospective cohort study (GGN-F) is to study the family aggregation of pulmonary ground glass nodules via the questionnaire survey and to investigate the underlying genetic mechanism via the biobank.

Unknown status4 enrollment criteria

Need Help? Contact our team!


We'll reach out to this number within 24 hrs